Systems and methods for fabricating microfluidic devices

Patent metadata

Field	Value
Publication number	US-12208385-B2
Application number	US-202217700031-A
Country	US
Kind code	B2
Filing date	Mar 21, 2022
Priority date	Aug 30, 2017
Publication date	Jan 28, 2025
Grant date	Jan 28, 2025

Abstract

This disclosure describes techniques for fabricating a high-resolution, non-cytotoxic and transparent microfluidic device. A material can be selected based on having an optical property with a predetermined degree of transparency to provide viewability of a biological sample through the microfluidic device and a level of cytotoxicity within a predetermined threshold to provide viability of the biological sample within the microfluidic device. An additive manufacturing technique can be selected from a plurality of additive manufacturing techniques for fabricating the microfluidic device based on the selected material to provide a resolution of dimensions of one or more channels of the microfluidic device higher than a predetermined resolution threshold.

First claim

What is claimed is:

1. A device comprising:
a construction comprising one or more channels having a resolution of dimensions higher than a threshold of less than 100, 150, 200 or 250 microns;
wherein the device is constructed using an additive manufacturing technique selected to provide the resolution of dimensions of the one or more channels higher than the threshold of less than 100, 150, 200 or 250 microns;
wherein a material used to construct the device provides for non-cytotoxicity over an extended period of time, optical transparency to visible light, reduced auto-fluorescence to enable data capture of the device operation via fluorescent images, and fabrication to reproduce features of less than 100 microns; and
wherein the material comprises at least 50%, or 60% or 70% by weight of polyethyl methacrylate polymer or copolymer.

2. The device of claim 1 , wherein the construction is a single piece or one piece construction.

3. The device of claim 1 , wherein the additive manufacturing technique is applied according to a parameter for layer thickness and a parameter for curing thickness offset in the range of about 0.01 millimeters to about 0.3 millimeters.

4. The device of claim 1 , wherein the additive manufacturing technique is one of 3D printing, stereolithography (SLA) or digital light projection stereolithography (SLA-DLP).

5. The device of claim 1 , wherein the one or more channels have a height in the range of about 0.01 millimeters to about 2.5 millimeters and a width in the range of about 0.01 millimeters to about 2.5 millimeter.

6. The device of claim 1 , wherein the material provided for survival of at least 90% of cells included in a biological sample over a period of at least one week.

7. The device of claim 1 , wherein the construction further comprises one or more bubble traps or one or more resistance lines.

8. A device comprising:
a construction comprising one or more channels having a resolution of dimensions higher than a threshold of less than 100, 150, 200 or 250 microns;
wherein the device is constructed using an additive manufacturing technique selected to provide the resolution of dimensions of the one or more channels higher than the threshold of less than 100, 150, 200 or 250 microns;
wherein the device is constructed by sequentially applying the additive manufacturing technique to a material to create a plurality of layers of the device, based on a model for the device specifying a plurality of parameters;
wherein the material used to construct the device provides for non-cytotoxicity over an extended period of time, optical transparency to visible light, reduced auto-fluorescence to enable data capture of the device operation via fluorescent images, and fabrication to reproduce features of less than 100 microns; and
wherein the material includes at least 50%, or 60% or 70% by weight of polyethyl methacrylate polymer or copolymer.

9. The device of claim 8 , wherein the construction is a single piece or one piece construction.

10. The device of claim 8 , wherein the plurality of parameters comprises a parameter for layer thickness and a predetermined parameter for curing thickness offset in the range of about 0.01 millimeters to about 0.3 millimeters.

11. The device of claim 8 , wherein the material comprises a polymer selected from a group consisting of polyetheretherketone (“PEEK”), polymethylacrylamide or polyacrylamide, polyvinylalcohol, polycaprolactone and polylactide.

12. The device of claim 8 , wherein the additive manufacturing technique is one of 3D printing, stereolithography (SLA) or digital light projection stereolithography (SLA-DLP).

13. The device of claim 8 , wherein the one or more channels have a height in the range of about 0.01 millimeters to about 2.5 millimeters and a width in the range of about 0.01 millimeters to about 2.5 millimeter.

14. The device of claim 8 , wherein the material provides for survival of at least 90% of cells included in a biological sample over a period of at least one week.

Assignees

• Charles Stark Draper Laboratory Inc
• Massachusetts Inst Technology
• The Charles Draper Laboratory Inc

Inventors

• Beckwith Ashley Lynne
• Borenstein Jeffrey
• Moore Nathan
• Doty Daniel
• Velásquez-García Luis

Classifications

• Y10T428/24744

  Longitudinal or transverse tubular cavity or cell · CPC title

• B81C1/00071

  Channels · CPC title

• B81B2203/0338

  Channels · CPC title

• B81B2201/058

  Microfluidics not provided for in B81B2201/051 - B81B2201/054 · CPC title

• B01L2200/12

  Specific details about manufacturing devices · CPC title